McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q1 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −98−100.0% | Sold out | Holders |
| Q2 2024 | 98 | $8.07K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 98 | $8.56K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 98 | $9.45K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 98 | $8.67K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 98 | $8.49K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 98 | $9.53K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 98 | $10.1K | <0.1% | +98 | New | Holders |